Loperamide Hydrochloride Solution
NDC Package 17856-6836-2
Package Information
Loperamide Hydrochloride (loperamide hcl) solution is see also Warning section. This formulation utilizes a solution delivery system. Marketed by Atlantic Biologicals Corp., this product is identified by NDC 17856-6836 and is authorized under FDA application ANDA091292.
Identification & Billing
- RxCUI: 1250685 - loperamide HCl 1 MG in 7.5 mL Oral Suspension
- RxCUI: 1250685 - loperamide hydrochloride 0.133 MG/ML Oral Suspension
- RxCUI: 1250685 - loperamide HCl 1 MG per 7.5 ML Oral Solution
- RxCUI: 1250685 - loperamide hydrochloride 1 MG per 7.5 ML Oral Suspension
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 17856 - Atlantic Biologicals Corp.
- 17856-6836 - Loperamide Hydrochloride
- 17856-6836-2 - 50 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE / 15 mL in 1 CUP, UNIT-DOSE (17856-6836-4)
- 17856-6836 - Loperamide Hydrochloride
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (17856-6836). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 17856-6836-2 identifies a specific commercial package of 50 cup, unit-dose in 1 box, unit-dose / 15 ml in 1 cup, unit-dose (17856-6836-4) of Loperamide Hydrochloride, a human over the counter drug labeled by Atlantic Biologicals Corp.. This solution is formulated for oral use and contains loperamide hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Atlantic Biologicals Corp. on November 29, 2018. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
See also Warning section. This medication is used to treat sudden diarrhea (including traveler's diarrhea). It works by slowing down the movement of the gut. This decreases the number of bowel movements and makes the stool less watery. Loperamide is also used to reduce the amount of discharge in patients who have had an ileostomy. It is also used to treat ongoing diarrhea in people with inflammatory bowel disease. Loperamide treats only the symptoms, not the cause of the diarrhea (e.g., infection). Treatment of other symptoms and the cause of the diarrhea should be determined by your doctor.
How is this Atlantic Biologicals Corp. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 17856683602. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.